Since calorie restriction improves longevity [83, 84], and metformin treatment just mimics dietary restriction, which highly upregulates AMPK activity while inhibits mTORC1 activity and NF-κB pathway, thereby modulating autophagy/senescence and ameliorating cardiovascular diseases [85, 86]. This evidence concerns the gene NFKB1 and cardiovascular disorder.